search icon
bivi-img

Biovie Inc Share Price

BIVI
NAQ
$1.16
-$0.08
(-6.45%)
1D
Industry: Biotechnology Sector: Health Care

Biovie Inc Analyst Forecast

Biovie Inc Share Price Chart

Biovie Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.35M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
84.44K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.52
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.1 L
$20.4 H
$1.16

About Biovie Inc, Common Stock

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. more

Industry: BiotechnologySector: Health Care

Biovie Inc Stock Returns

Time FrameBIVISectorS&P500
1-Week Return0.81%-1.52%0.41%
1-Month Return-6.77%0.12%1.81%
3-Month Return-27.49%7.78%1.82%
6-Month Return-79.33%17.05%10.26%
1-Year Return-92.25%5.6%16.37%
3-Year Return-99.78%16.99%67.04%
5-Year Return-99.97%34.45%82.38%
10-Year Return-99.9%137.3%266.85%

Biovie Inc Financials

Jun '21Jun '22Jun '23Jun '24Jun '255YR TREND
Total Revenue-----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Cost of Revenue229.38K237.42K266.84K229.38K229.38K[{"date":"2021-06-30","value":85.96,"profit":true},{"date":"2022-06-30","value":88.97,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":85.96,"profit":true},{"date":"2025-06-30","value":85.96,"profit":true}]
Gross Profit(229.38K)(237.42K)(266.84K)(229.38K)(229.38K)[{"date":"2021-06-30","value":-22937700,"profit":false},{"date":"2022-06-30","value":-23742100,"profit":false},{"date":"2023-06-30","value":-26684200,"profit":false},{"date":"2024-06-30","value":-22937700,"profit":false},{"date":"2025-06-30","value":-22937700,"profit":false}]
Gross Margin-----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Operating Expenses138.05M27.25M45.08M32.18M17.84M[{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":19.74,"profit":true},{"date":"2023-06-30","value":32.65,"profit":true},{"date":"2024-06-30","value":23.31,"profit":true},{"date":"2025-06-30","value":12.92,"profit":true}]
Operating Income(138.05M)(27.25M)(45.08M)(32.18M)(18.07M)[{"date":"2021-06-30","value":-13805400000,"profit":false},{"date":"2022-06-30","value":-2725297700,"profit":false},{"date":"2023-06-30","value":-4508044800,"profit":false},{"date":"2024-06-30","value":-3217958500,"profit":false},{"date":"2025-06-30","value":-1806620000,"profit":false}]
Total Non-Operating Income/Expense7.27M(950.40K)(8.91M)(1.70M)1.04M[{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-13.08,"profit":false},{"date":"2023-06-30","value":-122.65,"profit":false},{"date":"2024-06-30","value":-23.37,"profit":false},{"date":"2025-06-30","value":14.37,"profit":true}]
Pre-Tax Income(130.25M)(26.08M)(50.26M)(32.12M)(17.54M)[{"date":"2021-06-30","value":-13024900000,"profit":false},{"date":"2022-06-30","value":-2608446800,"profit":false},{"date":"2023-06-30","value":-5025581500,"profit":false},{"date":"2024-06-30","value":-3212053300,"profit":false},{"date":"2025-06-30","value":-1754212000,"profit":false}]
Income Taxes559.46K(3.29M)4.30M(229.38K)-[{"date":"2021-06-30","value":13.01,"profit":true},{"date":"2022-06-30","value":-76.44,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-5.33,"profit":false},{"date":"2025-06-30","value":"-","profit":true}]
Income After Taxes(130.81M)(22.80M)(54.56M)(31.89M)-[{"date":"2021-06-30","value":-13080845500,"profit":false},{"date":"2022-06-30","value":-2279746800,"profit":false},{"date":"2023-06-30","value":-5455581500,"profit":false},{"date":"2024-06-30","value":-3189115600,"profit":false},{"date":"2025-06-30","value":"-","profit":true}]
Income From Continuous Operations(130.25M)(26.08M)(50.26M)(32.12M)(17.54M)[{"date":"2021-06-30","value":-13024920400,"profit":false},{"date":"2022-06-30","value":-2608446800,"profit":false},{"date":"2023-06-30","value":-5025581500,"profit":false},{"date":"2024-06-30","value":-3212053300,"profit":false},{"date":"2025-06-30","value":-1754212000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Net Income(130.25M)(26.08M)(50.26M)(32.12M)(17.54M)[{"date":"2021-06-30","value":-13024900000,"profit":false},{"date":"2022-06-30","value":-2608446800,"profit":false},{"date":"2023-06-30","value":-5025581500,"profit":false},{"date":"2024-06-30","value":-3212053300,"profit":false},{"date":"2025-06-30","value":-1754212000,"profit":false}]
EPS (Diluted)(13.90)(1.12)(1.56)(1.53)(17.85)[{"date":"2021-06-30","value":-1390,"profit":false},{"date":"2022-06-30","value":-112,"profit":false},{"date":"2023-06-30","value":-156,"profit":false},{"date":"2024-06-30","value":-152.82,"profit":false},{"date":"2025-06-30","value":-1784.97,"profit":false}]

Biovie Inc Ratios

Biovie Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

BIVI
Cash Ratio 15.19
Current Ratio 15.83

Biovie Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BIVI
ROA (LTM) -50.01%
ROE (LTM) -94.79%

Biovie Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BIVI
Debt Ratio Lower is generally better. Negative is bad. 0.07
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.93

Biovie Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BIVI
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.38
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Biovie Inc share price today?

Biovie Inc (BIVI) share price today is $1.16

Can Indians buy Biovie Inc shares?

Yes, Indians can buy shares of Biovie Inc (BIVI) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BIVI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biovie Inc be purchased?

Yes, you can purchase fractional shares of Biovie Inc (BIVI) via the Vested app. You can start investing in Biovie Inc (BIVI) with a minimum investment of $1.

How to invest in Biovie Inc shares from India?

You can invest in shares of Biovie Inc (BIVI) via Vested in three simple steps:

  • Click on Sign Up or Invest in BIVI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biovie Inc shares
What is Biovie Inc 52-week high and low stock price?

The 52-week high price of Biovie Inc (BIVI) is $20.4. The 52-week low price of Biovie Inc (BIVI) is $1.1.

What is Biovie Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biovie Inc (BIVI) is

What is Biovie Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biovie Inc (BIVI) is 0.38

What is Biovie Inc dividend yield?

The dividend yield of Biovie Inc (BIVI) is 0.00%

What is the Market Cap of Biovie Inc?

The market capitalization of Biovie Inc (BIVI) is $9.35M

What is Biovie Inc's stock symbol?

The stock symbol (or ticker) of Biovie Inc is BIVI

How Can Investors Use Biovie Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Biovie Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biovie Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Biovie Inc shares for Indian investors?

When investing in Biovie Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biovie Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Biovie Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Biovie Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biovie Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top